Future research should focus on standardizing hs-cTnT measurement protocols, investigating the influence of patient characteristics and comorbidities, and assessing its predictive value in specific HF subgroups to enhance its clinical relevance. The gene discussed is TNNT2; the disease is hydrops fetalis.